Game Changer Drug For COVID-19 : "COVIFOR" by Hetero Company
DCGI endorsed Hetero Pharmaceuticals for the supply of drug Covifor (Remdesivir) to various states where the many suspected or laboratory-confirmed COVID cases are hospitalized because of drastic symptoms of the Corona virus.
Hetero stated that Covifor (Remdesivir) will be provided in a 100 mg vial (injectable) and must be administered intravenously in a hospital or intensive care unit under the supervision of a healthcare practitioner.
Now domestic pharmaceutical giant Hetero has begun to provide 20,000 bottles of Covifor (Remdesivir) generic drugs nationwide. The cost of the product is Rs 5,400 per bottle
What is Covifor?
Covifor is a generic version of Remdesivir drug which can be used in emergency conditions of Corona cases
It is a drug whose first batch will be supplied to Delhi, Maharastra, Gujrat etc.
The company is sure about enough stock to provide to the present requirements of the drug.
COVID-19 therapy by Covifor will cost less than 30,000 per patient. Six doses of the drug will be provided in the aforementioned timeframe.
By Subham Singha (Science & Tech Division)
IGNITED MINDS
News & Image Source - Click here
THANK YOU
Comments
Post a Comment